Academic Institute

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 78%
3. Genes 65%
4. Transplants 54%
5. Proteins 45%
6. Kidney 45%
7. Breast Neoplasms 45%
8. Lung 44%
9. T-Lymphocytes 43%
10. Mortality 38%
11. Brain 36%
12. Wounds and Injuries 36%
13. Survival 35%
14. Eye 34%
15. Coronary Vessels 33%
16. Blood Vessels 33%
17. Heart Failure 31%
18. DNA 31%
19. Population 31%
20. Infections 29%
21. Growth 29%
22. Stroke 28%
23. In Vitro Techniques 28%
24. Atherosclerosis 28%
25. Calcium 28%
26. Post-Traumatic Stress Disorders 28%
27. Mutation 27%
28. Coronary Artery Disease 27%
29. Pharmaceutical Preparations 27%
30. Magnetic Resonance Imaging 27%
31. Heart 27%
32. Equipment and Supplies 26%
33. Liver 26%
34. Safety 25%
35. Polychlorinated Dibenzodioxins 25%
36. Cardiovascular Diseases 25%
37. Neoplasm Metastasis 25%
38. Prostatic Neoplasms 24%
39. Carcinoma 24%
40. Allografts 24%
41. Myocardial Infarction 23%
42. Apoptosis 23%
43. Drug Therapy 23%
44. Gene Expression 23%
45. Biopsy 22%
46. Incidence 22%
47. Surgeons 22%
48. Radiotherapy 22%
49. Tomography 22%
50. Systematic Reviews 21%
51. Messenger RNA 21%
52. Guidelines 21%
53. Aryl Hydrocarbon Receptors 21%
54. Recurrence 20%
55. Placebos 20%
56. Phenotype 20%
57. Macrophages 20%
58. Skin 20%
59. Liver Transplantation 20%
60. Inflammation 20%
61. Confidence Intervals 20%
62. Biomarkers 20%
63. Tissue Donors 19%
64. Registries 19%
65. Parkinson Disease 19%
66. Pathology 19%
67. Antibodies 19%
68. Lung Neoplasms 19%
69. Veterans 18%
70. Genome 18%
71. Serum 18%
72. Prostate 18%
73. Technology 18%
74. Stents 18%
75. Adenocarcinoma 18%
76. Health 18%
77. Magnetic Resonance Spectroscopy 18%
78. Ligands 18%
79. Transcatheter Aortic Valve Replacement 18%
80. Randomized Controlled Trials 18%
81. Clinical Trials 18%
82. Stem Cells 17%
83. Transplant Recipients 17%
84. Cell Line 17%
85. Estrogen Receptors 17%
86. Pediatrics 17%
87. Child 17%
88. Breast 17%
89. Streptococcus 17%
90. Heart-Assist Devices 17%
91. Endothelial Cells 17%
92. Urinary Bladder 17%
93. Exercise 17%
94. Injections 17%
95. Costs and Cost Analysis 17%
96. Amyotrophic Lateral Sclerosis 17%
97. Transplantation 17%
98. Animals 16%
99. Cytokines 16%
100. Enzymes 16%